These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9230511)
41. [Value of prostate specific antigen in early diagnosis of prostatic cancer]. Xiao LP; Bi XJ; Li YN; Chen XQ; Zhang XF; Yu XP; Liu G; Yang MC; Song Z Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):107-8, 112. PubMed ID: 17259162 [TBL] [Abstract][Full Text] [Related]
42. A private medical reveals raised PSA. Walker B; Kirby M; Kirk D Practitioner; 2000 Jun; 244(1611):495-8, 500. PubMed ID: 10962841 [No Abstract] [Full Text] [Related]
43. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed]. Bratt O; Björk T Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615 [No Abstract] [Full Text] [Related]
44. [Prostate-specific antigen]. Eide IA; Angelsen A Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2528-31. PubMed ID: 11070990 [TBL] [Abstract][Full Text] [Related]
45. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters. Suzuki H; Akakura K; Igarashi T; Ueda T; Ito H; Watanabe M; Nomura F; Ochiai T; Shimada H J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872 [TBL] [Abstract][Full Text] [Related]
46. Are multiple markers the future of prostate cancer diagnostics? Mikolajczyk SD; Song Y; Wong JR; Matson RS; Rittenhouse HG Clin Biochem; 2004 Jul; 37(7):519-28. PubMed ID: 15234233 [TBL] [Abstract][Full Text] [Related]
47. [Prostate specific antigen: a role of PSA in the diagnosis of prostate cancer]. Nutahara K; Higashihara E Rinsho Byori; 2001 Oct; 49(10):963-6. PubMed ID: 11769472 [TBL] [Abstract][Full Text] [Related]
48. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer]. Medvedev VL Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295 [No Abstract] [Full Text] [Related]
49. [The assessment of pathological PSA values by the general practitioner--observation or intervention?]. Braun KP; Brookman-Amissah S; May M; Grassmel Y; Hoschke B; Braun V Aktuelle Urol; 2009 May; 40(3):171-4. PubMed ID: 19479670 [TBL] [Abstract][Full Text] [Related]
50. [Advanced prostate cancer with normal serum prostate-specific antigen values]. Komura T; Yamagiwa K; Ogura H; Kohjimoto Y; Ohkawa T; Inagaki T; Ebisuno S; Senzaki A Hinyokika Kiyo; 1998 May; 44(5):303-6. PubMed ID: 9656099 [TBL] [Abstract][Full Text] [Related]
51. PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence. Perrin P Eur Urol; 2006 Mar; 49(3):418-9. PubMed ID: 16459016 [No Abstract] [Full Text] [Related]
52. An overview of PSA/free PSA with special reference to recent trends in diagnosis of prostatic cancer. Goyal SR; Talib VH; Khurana SK Indian J Pathol Microbiol; 1999 Apr; 42(2):171-8. PubMed ID: 10639780 [No Abstract] [Full Text] [Related]
53. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues. Ito K Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638 [No Abstract] [Full Text] [Related]
60. [Localized prostate cancer. What to say to the patient?]. Coloby P Ann Urol (Paris); 2006 Dec; 40 Suppl 2():S18-23. PubMed ID: 17361914 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]